|
FREE patent keyword monitoring and additional FREE benefits. |
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Hetero Ring Is Four-membered And Includes At Least One Ring Nitrogen > Polycyclo Ring System Having The Four-membered Hetero Ring As One Of The Cyclos Polycyclo Ring System Having The Four-membered Hetero Ring As One Of The CyclosPolycyclo Ring System Having The Four-membered Hetero Ring As One Of The Cyclos patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.12/21/06 - 20060287290 - Azabicyclic compounds are central nervous system active agents are novel CNS active agents that are useful for treating pain and for treating other disorders associated with the cholinergic system. ... 11/30/06 - 20060270653 - Modulators of muscarinic receptors The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases. ... 08/31/06 - 20060194780 - Bicyclic piperidine derivatives as melanocortin-4 receptor agonists Certain novel bicyclic N-acylated piperidine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual ... 07/27/06 - 20060166962 - N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines It has now been found that certain novel N-(substituted aryl)-4-(disubstituted methyl)piperidine and pyridine derivatives have provided unexpected insecticidal activity. These compounds are represented by formula (I): wherein m, n, q, r, and s are independently selected from 0 or 1; and p is 0, 1, 2, or 3; A is ... 06/22/06 - 20060135504 - N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines It has now been found that certain novel N-(substituted aryl)-4(disubstituted methyl)piperidine and pyridine derivatives have provided unexpected insecticidal activity. These compounds are represented by formula (I): wherein m, n, q, r, and s are independently selected from 0 or 1; and p is 0, 1, 2, or 3; A is ... 06/08/06 - 20060122166 - Cyclohexyl compounds as ccr5 antagonists The present invention relates to compounds of formula (I), or pharmaceutically acceptable derivatives thereof, useful in the treatment of CCR5-related diseases and disorders, for example, useful in the inhibition of HIV replication, the prevention or treatment of an HIV infection, and in the treatment of the resulting acquired immune deficiency ... 10/20/05 - 20050234034 - Bicyclic and bridged nitrogen heterocycles Compounds are provided that act as potent modulators of one or more of the CCR1, CCR2 and CCR3 receptors. The compounds are generally fused-, spiro- or bridged-nitrogen heterocycles having an aryl and heteroaryl component and are useful in pharmaceutical compositions, methods for the treatment of CCR1-, CCR2- and/or CCR3-mediated diseases, ... 07/07/05 - 20050148573 - Benzimidazolone compounds having 5-ht4 receptor agonistic activity These compounds have 5-HT4 receptor agonistic activity, and thus are useful for the treatment of gastroesophageal reflux disease, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome or the like in mammalian, especially humans. ... ### FreshPatents.com Support |